AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2016
Nov 8, 2016
30786_dirs_2016-11-08_15598ee1-4a34-4306-aa2b-31e8e1a35083.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2016-11-04
Reporting Person: HERTIA JOHN (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-11-04 | Bio-Rad A Common Stock | M | 600 | — | Acquired | 10857 | Direct |
| 2016-11-07 | Bio-Rad A Common Stock | S | 227 | $165.62 | Disposed | 10630 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-11-04 | Restricted Stock Units | $0 | M | 600 | Disposed | Bio-Rad A Common Stock (600) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Bio-Rad A Common Stock | 252 | Indirect |
Footnotes
F1: Shares of Class A common stock acquired on the vesting of restricted stock units.
F2: Sold by the issuer on behalf of the reporting person to satisfy certain tax obligations in connection with the vesting of restricted stock units, all in accordance with a restricted stock unit award agreement.
F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4: The restricted stock units vest in five equal annual installments beginning November 4, 2012.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13